stability guidance -draft
...Stability studies for Drug for Injection products should include monitoring for appearance, clarity.....Significant change for a drug product at the accelerated stability condition and the.....include results from microbial challenge studies performed on the drug product at..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=100)
...FDA will maintain a requirement for reporting data from all ongoing product stability studies including.....Submit two copies of the annual progress report of postmarketing studies to the Food and Drug Administration.....A status report of each postmarketing study of the drug product concerning clinical safety..
http://www.fda.gov/OHRMS/DOCKETS/98fr/103000c.htm (score=56)
Human Drug Notes
...65 require that equipment used in processing of a drug product be suitable for its intended use.....drug product, stability studies should be conducted according to an approved stability protocol to.....In the latter case, until appropriate stability data is generated, the expiration date..
http://www.fda.gov/cder/hdn/hdn1295.htm (score=51)
HUMAN DRUG CGMP NOTES March 1999
...176 indicates that a non-penicillin drug product must not be marketed if detectable levels of.....The CGMP regulations allow for the use of accelerated stability studies to project a tentative.....Should investigators cite firms for not conducting accelerated stability testing during..
http://www.fda.gov/cder/hdn/cnotes39.htm (score=50)
ichq5c
...guidance to applicants regarding the type of stability studies that should be provided in support of.....either drug substance or drug product should be based on long-term, real-time, real.....formation are detected during long-term, accelerated, and/or stress stability studies,consideration..
http://www.fda.gov/cder/guidance/ichq5c.pdf (score=43)
...The quality of the final container product placed on stability studies should be representative of the quality of the.....However, it is strongly suggested that studies be conducted on the drug substance and drug product under accelerated.....Containers of reduced size may be acceptable for drug substance stability testing provided that they are..
http://www.fda.gov/cber/gdlns/ichq5c071096.txt (score=43)
Draft Guidance: ICH Q5E: Comparability of Biotechnological/Biological...
...Generally, therefore, real-time concurrent stability studies on the product potentially affected by the change.....The tests and analytical procedures chosen to define drug substance or drug product specifications alone are.....Furthermore, stability studies might be able to detect subtle differences that are not readily..
http://www.fda.gov/cber/gdlns/ichcompbio.htm (score=42)
Draft Guidance for Industry Comparability Protocols Protein Drug Products...
...2 The general term product as used in this guidance means drug substance, drug product, and intermediate, or in.....In a comparability protocol we recommend that you include a plan for the stability studies that will.....CMC changes on the identity, strength, quality, purity, and potency of a specific drug product..
http://www.fda.gov/OHRMS/DOCKETS/98fr/protcmc.pdf (score=38)
ICH: Final Guideline on Stability Testing of Biotechnological/Biological...
...analytical methods for the stability program, reference standards exist, the assay results.....the product retains its full potency, purity, biotechnological/biological products but are.....Food and Drug Administration, opportunity for tripartite harmonization.. ionic content..
http://www.fda.gov/cber/gdlns/ichq5c071096.pdf (score=37)
Packaging
...Samples of a drug that are selected for stability studies should be packaged in the container/clsoure system in which the drug.....It should provide an adequate seal, be compatible with the drug product, and not be a source of.....In these early stages, the IND should also indicate that appropriate stability studies with the..
http://www.fda.gov/cder/guidance/package.htm (score=36)
6003dft.doc
...therefore, real-time concurrent stability studies on the product potentially affected by.....changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cder/guidance/6003dft.pdf (score=36)
International Conference on Harmonisation; Draft Guidance on Q5E...
...therefore, real-time concurrent stability studies on the product potentially affected by.....changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cber/gdlns/ichcompbio.pdf (score=36)
Draft Guidance for Industry Comparability Protocols Protein Drug Products...
...2 The general term product as used in this guidance means drug substance, drug product, and intermediate, or in.....In a comparability protocol we recommend that you include a plan for the stability studies that will.....CMC changes on the identity, strength, quality, purity, and potency of a specific drug product..
http://www.fda.gov/cder/guidance/protcmc.pdf (score=32)
Consistent Container Information in an Abbreviated Application
...The stability section only describes the container as made from"HDPE resin with a metal.....batch number and strength of the drug product used, the source of the active drug..substance.....describe the container/closure system used in stability studies in terms that easily..relate to the..
http://www.fda.gov/cder/mapp/5225-2.pdf (score=31)
MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....conduct and/or complete prescribed studies on production batches of a drug after approval..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=30)
Format and Content for the CMC Section of an Annual Report
...the design of stability protocols, the amount of stability data that should be provided to.....Regulatory specifications and analytical methods for the drug substance and drug..product should be listed.....changed container and closure system in stability studies using the..approved stability..
http://www.fda.gov/cder/guidance/cmc1.pdf (score=29)
WAIS Document Retrieval
...Stability studies, knowledge of degradation pathways, product development studies, and laboratory.....Such studies should normally be conducted on the drug product or drug substance containing the degradation products to be controlled.....Safety studies should provide a comparison of results of safety testing of the drug product or drug..
http://www.fda.gov/cder/guidance/ichq3b.htm (score=28)
þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....should explain the scientific reasons why a stability indicating procedure is not viable.....dissolution or bioavailability of the drug product, and further studies on the drug..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=27)
Human Drug Notes
...Where an expiration dating period is derived from stability studies conducted on the repackaged drug.....The Division of Manufacturing and Product Quality, HFD-320 Office of Compliance Center for.....396 10 HUMAN DRUG CGMP NOTES March 1996 DIVISION OF MANUFACTURING AND PRODUCT QUALITY, HFD..
http://www.fda.gov/cder/hdn/hdn396.htm (score=27)
þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....should explain the scientific reasons why a stability indicating procedure is not viable.....dissolution or bioavailability of the drug product, and further studies on the drug..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=27)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
